Seres Therapeutics, Inc. Fair Value Adjustment of Warrants
Seres Therapeutics, Inc. (MCRB) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-03-12
- Seres Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- Seres Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00.
- Seres Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $0.00.
- Seres Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-03-31 was $0.00.
- Seres Therapeutics, Inc. fair value adjustment of warrants for fiscal 2025 was $0.00.
- Seres Therapeutics, Inc. fair value adjustment of warrants for fiscal 2024 was -$546.00K.
- Seres Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was -$1.55M.
- Seres Therapeutics, Inc. fair value adjustment of warrants for fiscal 2022 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | -$130.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | -$130.00K derived: sum of 3 quarters · filed 2026-03-12 | -$546.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$130.00K derived: sum of 2 quarters · filed 2025-11-05 | -$546.00K 10-Q · filed 2025-11-05 | -$956.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$546.00K 10-Q · filed 2025-08-06 | -$956.00K derived: sum of 3 quarters · filed 2026-03-12 | -$1.97M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$416.00K 10-Q · filed 2025-05-07 | -$826.00K derived: sum of 2 quarters · filed 2026-03-12 | -$1.84M derived: sum of 3 quarters · filed 2026-03-12 | -$1.97M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | -$410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.42M derived: sum of 2 quarters · filed 2026-03-12 | -$1.55M derived: sum of 3 quarters · filed 2026-03-12 | -$1.55M 10-K · filed 2026-03-12 |
| 2023-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$1.14M derived: sum of 2 quarters · filed 2024-11-13 | -$1.14M 10-Q · filed 2024-11-13 | -$1.14M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -$132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$132.00K 10-Q · filed 2024-08-13 | -$132.00K derived: sum of 3 quarters · filed 2025-03-13 | -$132.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-05 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $220.00K derived: sum of 3 quarters · filed 2018-03-08 | $7.00K 10-K · filed 2018-03-08 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $220.00K derived: sum of 2 quarters · filed 2016-11-10 | $7.00K 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $220.00K 10-Q · filed 2016-08-11 | $7.00K 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | -$213.00K 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $1.42M 10-K · filed 2017-03-16 | |||
| 2013-12-31 | $8.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |